We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Analyst: FTC Unlikely to Force Teva, Ivax to Sell Off Many Assets for Merger
Analyst: FTC Unlikely to Force Teva, Ivax to Sell Off Many Assets for Merger
October 13, 2005
Teva Pharmaceutical and Ivax will probably not have to sell off many products to consummate their pending merger, a Standard & Poor’s analyst said, despite an FTC request for more information about the proposed deal.